• Biosimilars
  • Drug Development/R&D
  • All Topics
OHE OHE
Newsletter SignupSubscribe

News & Insights
  • News
  • Events
  • Insights
  • Bulletin
  • News
  • Events
  • Insights
  • Bulletin

News & Insights

  • News
  • Events
  • Insights
  • Bulletin
Newsletter SignupSubscribe
  • News
  • Events
  • Insights
  • Bulletin

Close
OHE OHE
  • Research & Publications
  • News & Insights
  • Education
  • Innovation Policy Prize
  • Events
  • About Us
  • OHE Experts
  • Contact Us
Newsletter SignupSubscribe

Research & Publications

All Publications

Filter by:
  • Antimicrobial Resistance (AMR)
  • Biosimilars
  • Cell and Gene Therapies
  • Chronic Diseases
  • Combination Therapies
  • COVID-19 Research
  • Digital Health
  • Drug Development/R&D
  • Emerging Markets
  • EQ-5D and PROMs
  • Health Care Systems
  • Health Data and Statistics
  • Health Technology Assessment
  • Precision Medicine
  • Real World Evidence
  • Use of Medicines
  • Value-Based Pricing
  • Vaccine Research
  • Economics of Innovation
  • Measuring and Valuing Outcomes
  • Policy, Organisation and Incentives in Health Systems
  • Value, Affordability and Decision Making

News & Insights

  • News
  • Events
  • Insights
  • Bulletin

Education

  • Education Hub
  • OHE Graduate School
  • EVIA Programme

Innovation Policy Prize

  • The Prize Fund
  • 2022 Prize Fund

Latest Research & Publications

Proposal for a General Outcome-based Value Attribution Framework for Combination Therapies

CombTher_Adobe_photoguns_portrait
Read more
© photoguns
  • Digital Health

Navigating the Landscape of Digital Health – United Kingdom

Healthcare_Adobe_elenabsl
Read more

2021 OHE Annual Report to the Charity Commission

charityreport_lina-trochez-unsplash_landscape
Read more
© Lina Trochez/Unsplash

Supporting the Era of Green Pharmaceuticals in the UK

Sustainability_AdobeStock_270582392_landscape
Read more

Quality of life and wellbeing in individuals with experience of fertility problems and assisted reproductive techniques

Quality of life assisted reproduction Cover
Read more
  • Cell and Gene Therapies
  • Value, Affordability, and…

Health Technology Assessment of Gene Therapies: Are Our Methods Fit for Purpose?

gene_therapies_national-cancer-institute-unsplash_landscape
Read more
© NCI/Unsplash
  • Drug Development/R&D
  • Economics of Innovation
  • Health Policy and Regulation

Limitations of CBO’s Simulation Model of New Drug Development as a Tool for Policymakers

CBO-US_mayer-tawfik-K4Ckc0AxgDI-unsplash_landscape
Read more
© Mayer Tawfik/Unsplash
  • Measuring and Valuing Outcomes

When Generic Measures Fail to Reflect What Matters to Patients: Three Case Studies

PROMS_unsplash_National Cancer Institute_landscape
Read more
© NCI/Unsplash
Close
OHE
  • All Publications

    Filter by:
    • Antimicrobial Resistance (AMR)
    • Biosimilars
    • Cell and Gene Therapies
    • Chronic Diseases
    • Combination Therapies
    • COVID-19 Research
    • Digital Health
    • Drug Development/R&D
    • Emerging Markets
    • EQ-5D and PROMs
    • Health Care Systems
    • Health Data and Statistics
    • Health Technology Assessment
    • Precision Medicine
    • Real World Evidence
    • Use of Medicines
    • Value-Based Pricing
    • Vaccine Research
    • Economics of Innovation
    • Measuring and Valuing Outcomes
    • Policy, Organisation and Incentives in Health Systems
    • Value, Affordability and Decision Making
    • News
    • Events
    • Insights
    • Bulletin
    • Education Hub
    • OHE Graduate School
    • EVIA Programme
    • The Prize Fund
    • 2022 Prize Fund
  • Events
  • About Us
  • OHE Experts
  • Contact Us
Newsletter SignupSubscribe
Back
  • News
11 min read 26th September 2017

OHE at the EuroQol Plenary Meeting 2017

A summary of OHE researchers’ contributions to the 34th Plenary Meeting of the EuroQol Group in Barcelona. The EuroQol Group, founded in1987, is a global network of experts that initiated and continues to develop the EQ-5D, a generic measure of…

Share:
  •  Twitter
  •  LinkedIn
  •  Facebook
  • has-icon Email

A summary of OHE researchers’ contributions to the 34th Plenary Meeting of the EuroQol Group in Barcelona.

The EuroQol Group, founded in1987, is a global network of experts that initiated and continues to develop the EQ-5D, a generic measure of health outcome. The 34th Plenary Meeting of the EuroQol Group took place in Barcelona on 21st and 22nd September 2017. The Scientific Programme was chaired by Anna Krabbe-Lugnér and OHE’s Koonal Shah, while Mike Herdman (OHE’s Head of Health Outcomes) was one of the meeting’s local hosts. A number of OHE researchers attended the meeting, playing an active role in both the presentation and discussion of EQ-5D-related research.

Patricia Cubi-Molla presented a paper examining the concept of experience-based values. The paper proposes a framework in which the factor of ‘experience’ is detached from other factors, such as what is being valued, whose health state is being valued, and when the health state occurred. The results show that the role of experience is frequently disregarded or simplified in the reporting of health valuation studies. The paper was co-authored by Koonal Shah, and was discussed by Mimmi Åström.

Yan Feng presented a paper applying the innovative econometric methods used in modelling the EQ-5D-5L value set for England to the MVH study data underpinning the UK EQ-5D-3L value set. The study facilitates direct comparisons between the characteristics of the two value sets, and provides insights into how differences between them affect the distributions of EQ-5D-3L and EQ-5D-5L index data. The paper was co-authored by OHE’s Nancy Devlin and Ben van Hout of the University of Sheffield, and was discussed by Eleanor Pullenayegum.

Bernarda Zamora presented a paper reporting new methods for analysing the distribution of EQ-5D observations (previously reported at the 2017 PROMs research conference). The Health State Density Index and Health State Density Curve are used to summarise the extent to which people’s self-reported health on the EQ-5D is concentrated on a few health states, or distributed more evenly over a wide range of health states. This information can be useful in understanding patients’ treatment needs, as well as providing a way of comparing the nature of data provided by different patients or collected using different patient-reported outcome measures. Co-authors include OHE Senior Visiting Fellow David Parkin, and Andrew Bateman of the Cambridgeshire Community Services NHS Trust. The paper was discussed by Thomas Kohlmann.    

Paula Lorgelly and Mike Herdman both presented posters at the Plenary Meeting. Paula’s poster – co-authored by Richard Norman of Curtin University – compared the sensitivity of the EQ-5D (a generic instrument) to that of two cancer-specific instruments, the EORTC-8D and the QLU-C10D. Mike’s poster summarised key findings of a workshop on the use of minimally important differences in EQ-5D research. The poster was co-authored by OHE’s Nancy Devlin and David Mott, as well as researchers from APERSU, the Alberta PROMs and EQ-5D Research and Support Unit.

Mike also discussed a paper by Janine Verstraete on the influence that a child’s perceived general health has on the health status reported by their primary caregiver.

Finally, David, Koonal, Paula and Yan were included as co-authors on the following papers/posters led by collaborators at other institutions:

  • Norman, R., Viney, R., Mulhern, B., Brazier, J, Ratcliffe, J., Lancsar, E., Lorgelly, P., Street, D.J. and Flattery, M., 2017. A large Australian DCE with duration and dead to value EQ-5D-5L health states. [Paper]
  • Gutacker, N., Patton, N., Shah, K. and Parkin, D., 2017. The role of EQ-5D value sets based on patient preferences in the context of hospital choice in the national PROM programme in England. [Paper]
  • Flattery, M., Mulhern, B., Norman, R., Street, D., Feng, Y., et al. Valuing EQ-5D-5L in Australia using an adapted EQ-VT: Informing the further development of a revised valuation protocol. [Poster]

For more information about OHE’s programme of EuroQol-related research, please contact Nancy Devlin or Koonal Shah.

  • EQ-5D and PROMs
  • Measuring and Valuing Outcomes
  • Spotlight on OHE

Related News

  • News
  • November 2021

Opportunity Cost in Health Care: a Favourite Research Topic for OHE

Read more
  • News
  • May 2020

OHE Awarded Independent Research Organisation (IRO) Status by UKRI

Read more
  • News
  • February 2019

OHE Response to Public Consultation on NICE Principles

Read more
  • News
  • December 2018

OHE Achievements in 2018

Read more
footer_ohe_logo

Leading intellectual authority on global health economics

Sign Up for the OHE News Bulletin

Newsletter SignupStart Sign Up

Research & Publications

News & Insights

Innovation Policy Prize

Education

Events

About Us

OHE Experts

Contact Us

Sign Up for the OHE News Bulletin

Newsletter SignupStart Sign Up

The Office of Health Economics (OHE) is a company limited by guarantee registered in England and Wales (registered number 09848965) and its registered office is at 2nd Floor Goldings House, Hay’s Galleria, 2 Hay’s Lane, London, SE1 2HB.

Terms & Conditions

Privacy Policy

Cookies Policy

© 2023 Website Design

An error has occurred, please try again later.An error has occurred, please try again later.

We are using cookies to give you the best experience on our website.

You can find out more about which cookies we are using or switch them off in settings.

 Twitter
 Facebook
 LinkedIn
 Copy
 Email
Powered by  GDPR Cookie Compliance
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.

Strictly Necessary Cookies

Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.

If you disable this cookie, we will not be able to save your preferences. This means that every time you visit this website you will need to enable or disable cookies again.

3rd Party Cookies

This website uses Google Analytics to collect anonymous information such as the number of visitors to the site, and the most popular pages.

Keeping this cookie enabled helps us to improve our website.

Please enable Strictly Necessary Cookies first so that we can save your preferences!